Navigation Links
Oncothyreon announces clinical data from three product candidates presented at American Society of Clinical Oncology (ASCO) Annual Meeting
Date:5/30/2009

onal disease who received Stimuvax had a median survival of 30.6 months compared with 13.3 months for similar patients who did not receive the vaccine, a difference of 17.3 months. Long-term follow-up of these patients was conducted by Merck KGaA of Darmstadt, Germany, which assumed responsibility for the clinical development of Stimuvax in 2007."

Merck KGaA is conducting a global Phase 3 trial of Stimuvax known as START (Stimulating Targeted Antigenic Responses To NSCLC). START is a randomized, double-blind, placebo-controlled study that will evaluate patients with documented unresectable stage III NSCLC who have had a response or stable disease after at least two cycles of platinum based chemo-radiotherapy.

PX-866

Preliminary results of Oncothyreon's ongoing Phase 1 trial of PX-866, an inhibitor of PI-3 kinase, were presented by Dr. Antonio Jimenez, University of Colorado Cancer Center, Aurora, Colorado. Twenty-six patients have been treated in this trial at once daily doses ranging from 0.5 mg to 10 mg. The maximally tolerated dose has not yet been identified. The most common treatment-related adverse events at the doses tested include low-grade nausea, vomiting and diarrhea. Of 24 evaluable patients, six patients with previously progressive disease have had stable disease as their best response. Three of these patients remain on therapy. Pharmacodynamic monitoring has demonstrated inhibition of PI-3 kinase activity at doses as low as 1 mg per patient.

"We are excited to have seen stabilization of disease in previously progressing patients, as well as clearcut inhibition of PI-3 kinase activity, even in the early cohorts in this dose escalation trial," said Dr. Kirkman. "We believe these findings may reflect the fact that PX-866 is an irreversible inhibitor of PI-3 kinase, which distinguishes it from other PI-3 kinase inhibitors currently in clinical development."

PX-12

'/>"/>
SOURCE Oncothyreon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Biomira announces plan to change name to Oncothyreon
2. Oncothyreon highlights corporate and clinical objectives for 2008
3. Oncothyreon to present at BIO CEO & Investor Conference
4. Oncothyreon launches new corporate website
5. Oncothyreons PX-478 is effective in preclinical model of human lung cancer
6. Oncothyreon announces March 10th webcast of fourth quarter and full year financial results conference call
7. Oncothyreon reports full year and fourth quarter 2007 financial results
8. Oncothyreon to present at upcoming investment conferences
9. Oncothyreon announces issuance of patent for PX-867
10. Oncothyreon announces effectiveness of shelf registration statement
11. Oncothyreon announces data from multiple small molecule programs to be presented at American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014 ... the addition of the  "Global Hormone Replacement ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ,Hormone replacement ... a means of replacing hormones that are ... This type of therapy is usually initiated ...
(Date:8/21/2014)... New Rochelle, N.Y. (PRWEB) August 21, 2014 ... it is the first private college in the Mid-Hudson ... The College will now begin accepting applications from qualified ... , “We are very pleased to have been ... to support Governor Cuomo’s transformative initiative to stimulate economic ...
(Date:8/21/2014)... NEW YORK , Aug. 21, 2014 /PRNewswire/ ... OTCM) congratulates Immune Pharmaceuticals Inc., a biotechnology company, ... Capital Market.  Immune previously traded on OTCQX®, the ... operated by OTC Markets Group. Logo - ... Immune Pharmaceuticals on the successful execution of its ...
(Date:8/21/2014)... Chester, NJ (PRWEB) August 21, 2014 ... of personal selling optimization technology and services for ... publication of “Grading Pharma’s Use of New Commercial ... of Measurement & Analytics. , The article examines ... marketing yield that are being tested in the ...
Breaking Biology Technology:Global Hormone Replacement Therapy Market 2014-2018: Key Vendors are Actavis, Bayer, Merck & Co, Novartis and Novo Nordisk 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 2The College of New Rochelle Becomes First Private College in Mid-Hudson Region to Earn START-UP NY Designation 3OTC Markets Group Congratulates Immune Pharmaceuticals on NASDAQ Listing 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2
... 14 (http://www.amdl.com ) AMDL,Inc., (Amex: ADL ... in China and the US, announced that the,AMDL-ELISA DR- ... useful test for the,detection of cancer in clinical practice ... Medical Department II at the University Hospital,in Frankfurt Germany. ...
... Liquids) will be held in Göteborg, Sweden on October 13-14, 2008 ... discussing commercialization of BTL. Technological advancements & worldwide growth of BTL ... insights on biomass to liquid industry prospect , ... ...
... Rankings Include 170 Hospitals and Medical Centers in 16 Specialties, ... 19 Hospitals Included in ... Group today,announced the 2008 publication of America,s Best Hospitals, accessible,today ... July 14., Authoritative and influential, the 2008 America,s Best ...
Cached Biology Technology:AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test 2AMDL ELISA DR-70(R) (FDP) is Promising as Effective Cancer Detection Test 3Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments? 2Will New Technological Advances Offer Fresh Capabilities for Commercialization and Enhance BTL Investments? 3U.S. News Media Group Releases 19th Edition of America's Best Hospitals 2U.S. News Media Group Releases 19th Edition of America's Best Hospitals 3
(Date:8/21/2014)... RUSTON, La. A team of researchers ... innovative method for using affordable, consumer-grade 3D ... implants that can contain antibacterial and chemotherapeutic ... team comprised of doctoral students and research ... nanosystems engineering programs collaborated to create filament ...
(Date:8/21/2014)... Carolina State University have developed a novel and versatile ... applications for creating new materials as well as for ... technique allows us to model much larger and more ... quickly," says Nan Li, lead author of a paper ... State,s Department of Materials Science and Engineering. "This is ...
(Date:8/20/2014)... a John and Rebecca Moores Professor of Biology and Biochemistry ... in the International Society for the Study of the Origin ... members two from the U.S., one from France and ... are elected every three years, and 36 have been named ... 20 countries, the ISSOL includes researchers from disciplines as varied ...
Breaking Biology News(10 mins):Louisiana Tech University researchers use 3D printers to create custom medical implants 2Louisiana Tech University researchers use 3D printers to create custom medical implants 3Researchers develop models to study polyelectrolytes, including DNA and RNA 2UH professor named fellow by International Astrobiology Society 2
... mouth bacteria behaving badly and the hundreds of microbial ... of the highlights at the Society for General Microbiology,s ... event takes place on 6-9 September at the Jubilee ... will present cutting-edge scientific research covering a wide range ...
... Ohio Normally, the brilliant red of a male cardinal ... that may not be true of cardinals living in urban ... bright red feather coloration of male northern cardinals (Cardinalis cardinalis) ... urban forests than it is for those in rural forests. ...
... Penetrating pores . . . Using neutron scattering ... of the country, Larry Anovitz, David Cole and Gernot Rother ... geologic processes. The researchers are especially interested in studying how ... can range from nano-scale to room-size and are a primary ...
Cached Biology News:Study: The bright red of cardinals means less in urban areas 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, September 2010 2Story tips from the US Department of Energy's Oak Ridge National Laboratory, September 2010 3
Raised to 5-HIAA coupled to BSA with paraformaldehyde....
Request Info...
NuCycl DAPI Kit Application: Flow Cytometry Reactivity: Human...
Anti-hamster Ig HRP detection kit...
Biology Products: